These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26092777)

  • 1. Estimating demand for a new contraceptive method: projections for the introduction of Sayana Press.
    Khan S; Grady B; Tifft S
    Int J Gynaecol Obstet; 2015 Aug; 130 Suppl 3():E21-4. PubMed ID: 26092777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of the community-level provision of Sayana® Press by medical and nursing students in Kinshasa, Democratic Republic of the Congo.
    Bertrand JT; Makani PB; Hernandez J; Akilimali P; Mukengeshayi B; Babazadeh S; Binanga A
    Contraception; 2017 Sep; 96(3):211-215. PubMed ID: 28647500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot Research as Advocacy: The Case of Sayana Press in Kinshasa, Democratic Republic of the Congo.
    Binanga A; Bertrand JT
    Glob Health Sci Pract; 2016 Dec; 4(4):542-551. PubMed ID: 27979874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home-based administration of Sayana® Press: review and assessment of needs in low-resource settings.
    Keith B; Wood S; Tifft S; Hutchings J
    Contraception; 2014 May; 89(5):344-51. PubMed ID: 24813924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of home and self-injection of Sayana® Press in Ethiopia: a qualitative study.
    Keith B; Wood S; Chapman C; Alemu E
    Contraception; 2014 May; 89(5):379-84. PubMed ID: 24529492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of the contraceptive Sayana® Press when injected every four months: Results from a twelve-month trial in Brazil, Chile and the Dominican Republic.
    Burke HM; Packer C; Fuchs R; Brache V; Bahamondes L; Salinas A; Veiga N; Miller A; Deese J
    Contraception; 2022 Sep; 113():95-100. PubMed ID: 35483431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective cohort study to assess the acceptability of Sayana Press among 18-49-year-old women in Nepal.
    Sherpa LY; Tinkari BS; Gentle P; Sah RK; Shrestha A; Sahani SK; Aryal K; Ghimire J; Karki DK
    Contraception; 2021 Dec; 104(6):623-627. PubMed ID: 34280441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operational assessments of Sayana® Press provision in Senegal and Uganda.
    Cover J; Blanton E; Ndiaye D; Walugembe F; Lamontagne DS
    Contraception; 2014 May; 89(5):374-8. PubMed ID: 24565737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
    Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
    Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manufacturer's response to letter about 'Sayana Press and a case of likely lipoatrophy'.
    Patel S
    BMJ Sex Reprod Health; 2018 Oct; 44(4):314. PubMed ID: 30305410
    [No Abstract]   [Full Text] [Related]  

  • 11. Progestin-only contraception: injectables and implants.
    Jacobstein R; Polis CB
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):795-806. PubMed ID: 24996766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The strategic approach to contraceptive introduction.
    Simmons R; Hall P; Díaz J; Díaz M; Fajans P; Satia J
    Stud Fam Plann; 1997 Jun; 28(2):79-94. PubMed ID: 9216029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
    Burke HM; Mueller MP; Packer C; Perry B; Bufumbo L; Mbengue D; Daff BM; Mbonye A
    Contraception; 2014 May; 89(5):368-73. PubMed ID: 24576792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sayana® Press: can it be a "game changer" for reducing unmet need for family planning?
    Spieler J
    Contraception; 2014 May; 89(5):335-8. PubMed ID: 24703826
    [No Abstract]   [Full Text] [Related]  

  • 15. Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial.
    Deese J; Brache V; Bahamondes L; Salinas A; Jorge A; Veiga N; Fuchs R; Miller A; Taylor D; Halpern V; Dorflinger L
    EClinicalMedicine; 2022 Feb; 44():101273. PubMed ID: 35128365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discussion--meeting contraceptive needs worldwide: the role of monthly combined injectables.
    Sciarra JJ
    Int J Gynaecol Obstet; 1998 Aug; 62 Suppl 1():S41-2. PubMed ID: 9806238
    [No Abstract]   [Full Text] [Related]  

  • 17. Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.
    Burke HM; Mueller MP; Perry B; Packer C; Bufumbo L; Mbengue D; Mall I; Daff BM; Mbonye AK
    Contraception; 2014 May; 89(5):361-7. PubMed ID: 24631328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demand for long acting contraceptive methods and associated factors among family planning service users, Northwest Ethiopia: a health facility based cross sectional study.
    Yalew SA; Zeleke BM; Teferra AS
    BMC Res Notes; 2015 Feb; 8():29. PubMed ID: 25656470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth intervals and injectable contraception in sub-Saharan Africa.
    Ngianga-Bakwin K; Stones RW
    Contraception; 2005 May; 71(5):353-6. PubMed ID: 15854636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction strategies raise key questions.
    Finger WR; Keller S
    Netw Res Triangle Park N C; 1995 Sep; 16(1):4-8. PubMed ID: 12290471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.